BMPR2 is required for postimplantation uterine function and pregnancy maintenance.

TitleBMPR2 is required for postimplantation uterine function and pregnancy maintenance.
Publication TypeJournal Article
Year of Publication2013
AuthorsNagashima T, Li Q, Clementi C, Lydon JP, Demayo FJ, Matzuk MM
JournalThe Journal of clinical investigation
Volume123
Issue6
Pagination2539-50
Date Published2013 Jun 3
Abstract

Abnormalities in cell-cell communication and growth factor signaling pathways can lead to defects in maternal-fetal interactions during pregnancy, including immunologic rejection of the fetal/placental unit. In this study, we discovered that bone morphogenetic protein receptor type 2 (BMPR2) is essential for postimplantation physiology and fertility. Despite normal implantation and early placental/fetal development, deletion of Bmpr2 in the uterine deciduae of mice triggered midgestation abnormalities in decidualization that resulted in abnormal vascular development, trophoblast defects, and a deficiency of uterine natural killer cells. Absence of BMPR2 signaling in the uterine decidua consequently suppressed IL-15, VEGF, angiopoietin, and corin signaling. Disruption of these pathways collectively lead to placental abruption, fetal demise, and female sterility, thereby placing BMPR2 at a central point in the regulation of several physiologic signaling pathways and events at the maternal-fetal interface. Since trophoblast invasion and uterine vascular modification are implicated in normal placentation and fetal growth in humans, our findings suggest that abnormalities in uterine BMPR2-mediated signaling pathways can have catastrophic consequences in women for the maintenance of pregnancy.

DOI10.1093/jxb/ert290
Alternate JournalJ. Clin. Invest.